These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39177013)

  • 1. Topical amitriptyline in burning mouth syndrome: A retrospective real-world evidence study.
    Lebel A; Da Silva Vieira D; Boucher Y
    Headache; 2024 Oct; 64(9):1167-1173. PubMed ID: 39177013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.
    Lynch ME; Clark AJ; Sawynok J; Sullivan MJ
    J Pain; 2005 Oct; 6(10):644-9. PubMed ID: 16202956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amitriptyline at low dose for burning mouth syndrome.
    Nagamine T
    Oral Dis; 2024 Oct; 30(7):4650-4652. PubMed ID: 38622839
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressants for chronic non-cancer pain in children and adolescents.
    Cooper TE; Heathcote LC; Clinch J; Gold JI; Howard R; Lord SM; Schechter N; Wood C; Wiffen PJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012535. PubMed ID: 28779487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.
    Takenoshita M; Motomura H; Toyofuku A
    Pain Med; 2017 Apr; 18(4):814-815. PubMed ID: 27558854
    [No Abstract]   [Full Text] [Related]  

  • 8. An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome.
    Kawasaki K; Nagamine T; Watanabe T; Suga T; Tu TTH; Sugawara S; Mikuzuki L; Miura A; Shinohara Y; Yoshikawa T; Takenoshita M; Toyofuku A
    Asia Pac Psychiatry; 2018 Sep; 10(3):e12315. PubMed ID: 29575764
    [No Abstract]   [Full Text] [Related]  

  • 9. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
    Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
    J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for treating burning mouth syndrome.
    McMillan R; Forssell H; Buchanan JA; Glenny AM; Weldon JC; Zakrzewska JM
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002779. PubMed ID: 27855478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of topical amitriptyline in neuropathic pain: two cases and literature review.
    Kopsky DJ; Hesselink JM
    Pain Pract; 2012 Feb; 12(2):148-53. PubMed ID: 21676162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five Patients With Burning Mouth Syndrome in Whom an Antidepressant (Serotonin-Noradrenaline Reuptake Inhibitor) Was Not Effective, but Pregabalin Markedly Relieved Pain.
    Ito M; Tokura T; Yoshida K; Nagashima W; Kimura H; Umemura E; Tachibana M; Miyauchi T; Kobayashi Y; Arao M; Ozaki N; Kurita K
    Clin Neuropharmacol; 2015; 38(4):158-61. PubMed ID: 26166242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome.
    Nagamine T; Watanabe T; Toyofuku A
    Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):33-36. PubMed ID: 38285063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome.
    Jørgensen MR; Pedersen AM
    Acta Odontol Scand; 2017 Mar; 75(2):130-136. PubMed ID: 28007005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
    Paudel D; Utsunomiya M; Yoshida K; Giri S; Uehara O; Matsuoka H; Chiba I; Toyofuku A; Abiko Y
    Oral Dis; 2020 Jan; 26(1):193-199. PubMed ID: 31705718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Rice AS; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007393. PubMed ID: 28085183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tretinoin treatment for burning mouth syndrome: a pilot study.
    Haviv Y; Merimsky B; Kay Z; Sharav Y; Czerninski R; Brotman Y; Klutstein M; Aframian DJ
    Quintessence Int; 2022 Oct; 53(10):860-867. PubMed ID: 35976748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study.
    Petruzzi M; Lauritano D; De Benedittis M; Baldoni M; Serpico R
    J Oral Pathol Med; 2004 Feb; 33(2):111-4. PubMed ID: 14720197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.